Latest filing published 20 Oct 2020 for Aligos Therapeutics, Inc..
Insider track record
No signal scores available.
Leonid Beigelman: trading record in brief
Leonid Beigelman appears in our data through filings on Aligos Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 9 filings, all for trades on 20 October 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 20 October 2020, the filings show a transaction in Aligos Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leonid Beigelman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 163,842 sharesCommon StockSEC:0001567619-20-018000:0
- 13,559 sharesCommon StockSEC:0001567619-20-018000:1
- 13,559 sharesCommon StockSEC:0001567619-20-018000:2
- 50,781 sharesCommon StockSEC:0001567619-20-018000:3
- 3,359 sharesCommon StockSEC:0001567619-20-018000:4
- 3,359 sharesCommon StockSEC:0001567619-20-018000:5
- 21,724 sharesCommon StockSEC:0001567619-20-018000:6
- 1,437 sharesCommon StockSEC:0001567619-20-018000:7
- 1,437 sharesCommon StockSEC:0001567619-20-018000:8
9 of 9 declarations
